Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

Abstract

Background

Epstein–Barr virus (EBV) is associated with MS, but it is not clear whether EBV plays a role in the pathogenesis of MS.

Hypothesis

We hypothesized that the immune control of EBV might be defective in MS, and that reactivation of EBV might drive the immune response in MS.

Methods

We collected blood from controls and patients with MS, and measured the amounts of EBV DNA and RNA using quantitative PCR.

Results

We found that EBV DNA and RNA were frequently detectable in peripheral blood leukocytes from both patients with MS and normal controls. There was no significant difference between patients with MS or controls. Paired samples from a small number of subjects suggest that EBV DNA may increase before and during clinical relapse.

Conclusions

We conclude that the immune control of EBV infection is similar in MS and controls, and that reactivation of EBV may correlate with MS disease activity.

Keywords

Epstein–Barr virus multiple sclerosis quantitative PCR relapse

Get full access to this article

View all access options for this article.

References

1 Ascherio A Munch M . Epstein-Barr virus and multiple sclerosis. Epidemiology 2000; 11: 220–224.

2 Banwell B Krupp L Kennedy J . Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 2007; 6: 773–781.

3 Pohl D Krone B Rostasy K . High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006; 67: 2063–2065.

4 Alotaibi S Kennedy J Tellier R Stephens D Banwell B . Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291: 1875–1879.

5 Ascherio A Munger KL Lennette ET . Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001; 286: 3083–3088.

6 Sundstrom P Juto P Wadell G . An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004; 62: 2277–2282.

7 Levin LI Munger KL Rubertone MV . Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496–2500.

8 DeLorenze GN Munger KL Lennette ET Orentreich N Vogelman JH Ascherio A . Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006; 63: 839–844.

9 Serafini B Rosicarelli B Franciotta D . Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899–2912.

10.

10 Alvarez-Lafuente R De Las Heras V Bartolome M Garcia-Montojo M Arroyo R . Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol 2006; 16: 20–27.

11.

11 Lunemann JD Edwards N Muraro PA . Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006; 129: 1493–1506.

12.

12 Wandinger K Jabs W Siekhaus A . Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000; 55: 178–184.

13.

13 Buljevac D van Doornum GJ Flach HZ . Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 1377–1381.

14.

14 Hollsberg P Kusk M Bech E Hansen HJ Jakobsen J Haahr S . Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity. Acta Neurol Scand 2005; 112: 395–402.

15.

15 Kang I Quan T Nolasco H . Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 2004; 172: 1287–1294.

16.

16 Balandraud N Meynard JB Auger I . Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum 2003; 48: 1223–1228.

17.

17 Villoslada P Juste C Tintore M . The immune response against herpesvirus is more prominent in the early stages of MS. Neurology 2003; 60: 1944–1948.

18.

18 Martin C Enbom M Soderstrom M . Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997; 95: 280–283.

19.

19 Ferrante P Omodeo-Zorini E Zuffolato MR . Human T-cell lymphotropic virus tax and Epstein-Barr virus DNA in peripheral blood of multiple sclerosis patients during acute attack. Acta Neurol Scand Suppl 1997; 169: 79–85.

20.

20 Sotelo J Ordonez G Pineda B . Varicella-zoster virus at relapses of multiple sclerosis. J Neurol 2007; 254: 493–500.